Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

NCT03533920 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma Non-resectable

Interventions

DEVICE: UNI-DEB

Sponsor

Jeil Pharmaceutical Co., Ltd.